Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

361.34
BATS BZX Real-Time Price
As of 12:23pm ET
 +10.56 / +3.01%
Today’s Change
271.37
Today|||52-Week Range
442.00
-3.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$37.2B

Company Description

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Contact Information

Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown New York 10591-6707
P:(914) 847-7000
Investor Relations:
(914) 847-3482

Employees

Shareholders

Mutual fund holders42.78%
Other institutional27.01%
Individual stakeholders24.29%

Top Executives

There are no executives to display.